22/04/2020

Serological Testing

A joint action between five Portuguese research institutions – IGC, iMM, iBET, CEDOC-NMS, ITQB-NOVA – Serology4COVID consortium – is developing a new serological test for COVID-19. The implementation of a scalable and economical serological test is essential to understand the expansion of immunity in the population and to support the implementation of new strategies to control the spread and/or minimize its consequences for health, society and the economy.

IGC iMM

 

The Champalimaud Foundation, in collaboration with the Order of Nurses, has started a study with serological tests that aims to assess the existence of antibodies to SARS-Cov-2 in about 600 health professionals (nurses and operational assistants) in two major hospitals that are very active in the treatment of COVID-19 patients – Hospital de Santo António, in Porto, and Hospital de Santa Maria, in Lisbon.

Champalimaud Foundation

 

Other Collaborative Efforts